ETR:HNL

Dr. Hönle AG (HNL.F) Stock Forecast, Price & News

€47.15

-0.25 (-0.53 %)

(As of 02/23/2021 12:00 AM ET)

Add

Compare

Today's Range

€43.75

Now: €47.15▼

€48.00

50-Day Range

€47.40

MA: €53.74▼

€57.40

52-Week Range

€24.45

Now: €47.15▼

€60.40

Volume77,425 shs

Average VolumeN/A

Market Capitalization$285.82 million

P/E Ratio55.93

Dividend Yield1.05%

BetaN/A

Dr. HÃ¶nle AG operates in the UV market worldwide. It operates through three segments: Equipment & Systems, Glass & Lamps, and Adhesives. The Equipment & Systems segment offers UV equipment and systems, LED-UV units, IR units, inert systems, disinfection systems, solar simulation systems and light fixtures, lighting systems, UV measuring technology products, UV-adhesives, and components and replacement parts. This segment also provides hot air systems, and powder spraying and extraction systems for sheet-fed offset printing; UV dryers for Web printing; UV systems with nitrogen inertisation; and drying systems. Its products are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Glass & Lamps segment offers UV low and medium pressure lamps; infrared emitters; electronic power supplies; UV sensors and measuring technology products; UV measuring devices; and submersible and immersion tube systems, as well as accessories. This segment also provides UV bulbs; and quartz glass tubing and rods for the lamp, automotive, semiconductor, and fiber cable industries. The Adhesives segment offers industrial, UV, medical grade, and conductive adhesives; dosing systems; potting and sealing compounds; and UV curing units. Dr. HÃ¶nle AG was founded in 1976 and is headquartered in GrÃ¤felfing, Germany.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange ETR

Industry Electronic Components

Sub-IndustryN/A

SectorComputer and Technology

Current SymbolETR:HNL

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.hoenle.de

Phone49 89 85608 0

Employees580

Year FoundedN/A

Debt

Debt-to-Equity Ratio48.18

Current Ratio3.81

Quick Ratio2.03

Price-To-Earnings

Trailing P/E Ratio55.93

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$95.34 million

Price / Sales3.00

Cash Flow€5.58 per share

Price / Cash Flow8.45

Book Value€19.44 per share

Price / Book2.43

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares6,061,850

Market Cap$285.82 million

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.49 out of 5 stars

3.5 Analyst's Opinion

Consensus Rating
Dr. Hönle AG (HNL.F) has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of €66.75, Dr. Hönle AG (HNL.F) has a forecasted upside of 41.6% from its current price of €47.15.
Amount of Analyst Coverage
Dr. Hönle AG (HNL.F) has only been the subject of 2 research reports in the past 90 days.

2.5 Community Rank

Outperform Votes
Dr. Hönle AG (HNL.F) has received 18 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Dr. Hönle AG (HNL.F) has received 18 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Dr. Hönle AG (HNL.F) has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Dr. Hönle AG (HNL.F) and other stocks. Vote “Outperform” if you believe HNL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HNL will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
Dr. Hönle AG (HNL.F) has a dividend yield of 1.05%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Dr. Hönle AG (HNL.F) does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Dr. Hönle AG (HNL.F) is 59.31%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Dr. Hönle AG (HNL.F) insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Dr. Hönle AG (HNL.F) is 55.93, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 33.02.
Price to Earnings Ratio vs. Sector
The P/E ratio of Dr. Hönle AG (HNL.F) is 55.93, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 71.41.
Price to Book Value per Share Ratio
Dr. Hönle AG (HNL.F) has a P/B Ratio of 2.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

€47.15

-0.25 (-0.53 %)

(As of 02/23/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive HNL News and Ratings via Email

Sign-up to receive the latest news and ratings for HNL and its competitors with MarketBeat's FREE daily newsletter.

Dr. Hönle AG (HNL.F) (ETR:HNL) Frequently Asked Questions

Is Dr. Hönle AG (HNL.F) a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dr. Hönle AG (HNL.F) in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Dr. Hönle AG (HNL.F) stock.
View analyst ratings for Dr. Hönle AG (HNL.F) or view top-rated stocks.

What stocks does MarketBeat like better than Dr. Hönle AG (HNL.F)?

Wall Street analysts have given Dr. Hönle AG (HNL.F) a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Dr. Hönle AG (HNL.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Dr. Hönle AG (HNL.F)'s stock been impacted by Coronavirus (COVID-19)?

Dr. Hönle AG (HNL.F)'s stock was trading at €34.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, HNL shares have increased by 37.1% and is now trading at €47.15.
View which stocks have been most impacted by COVID-19.

Is Dr. Hönle AG (HNL.F) a good dividend stock?

Dr. Hönle AG (HNL.F) pays an annual dividend of €0.50 per share and currently has a dividend yield of 1.05%. The dividend payout ratio of Dr. Hönle AG (HNL.F) is 59.31%. This payout ratio is at a healthy, sustainable level, below 75%.
View Dr. Hönle AG (HNL.F)'s dividend history.

What price target have analysts set for HNL?

2 Wall Street analysts have issued twelve-month target prices for Dr. Hönle AG (HNL.F)'s stock. Their forecasts range from €65.00 to €68.50. On average, they anticipate Dr. Hönle AG (HNL.F)'s stock price to reach €66.75 in the next year. This suggests a possible upside of 41.6% from the stock's current price.
View analysts' price targets for Dr. Hönle AG (HNL.F) or view top-rated stocks among Wall Street analysts.

Who are Dr. Hönle AG (HNL.F)'s key executives?

Dr. Hönle AG (HNL.F)'s management team includes the following people:

Dr. Norbert Haimerl M.B.A., CFO. MD of IT, HR & Investor Relations and Member of Management Board (Age 59, Pay $898k)
Mr. Heiko Runge Grad. Eng., MD of Sales & Marketing and Member of Management Board (Age 57, Pay $866k)
Mr. Rainer Pumpe, MD of Devel. & Production and Member of the Management Board
Peter Weinert, Head of Investor Relations

Who are some of Dr. Hönle AG (HNL.F)'s key competitors?

Some companies that are related to Dr. Hönle AG (HNL.F) include discoverIE Group (DSCV), Strix Group (KETL), Luceco (LUCE), FW Thorpe Plc (TFW.L) (TFW), Gooch & Housego (GHH), Ilika (IKA), Electrovaya Inc. (EFL.TO) (EFL), KULR Technology Group (KULR), Hammond Power Solutions (HPS.A), Xaar (XAR), Trackwise Designs (TWD), NexOptic Technology (NXO), CAP-XX (CPX), Windar Photonics (WPHO) and Smartcool Systems Inc. (SSC.V) (SSC).
View all of HNL's competitors.

What is Dr. Hönle AG (HNL.F)'s stock symbol?

Dr. Hönle AG (HNL.F) trades on the ETR under the ticker symbol "HNL."

What is Dr. Hönle AG (HNL.F)'s stock price today?

One share of HNL stock can currently be purchased for approximately €47.15.

How much money does Dr. Hönle AG (HNL.F) make?

Dr. Hönle AG (HNL.F) has a market capitalization of $285.82 million and generates $95.34 million in revenue each year.

How many employees does Dr. Hönle AG (HNL.F) have?

Dr. Hönle AG (HNL.F) employs 580 workers across the globe.

What is Dr. Hönle AG (HNL.F)'s official website?

The official website for Dr. Hönle AG (HNL.F) is www.hoenle.de.

How can I contact Dr. Hönle AG (HNL.F)?

The company can be reached via phone at 49 89 85608 0.

This page was last updated on 2/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here